Sopharma AD

Annual / Quarterly Financial Statement • Apr 24, 2024

Out. number: 194-00-23/25.04.2024

Publication of the Annual Audited Consolidated Financial Statements of "Sopharma" AD as at 31 December 2023

Sofia, Bulgaria, 25 April 2024 – According to the requirements of art. 100n of LPOS, "Sopharma" AD (SFA: "BSE-Sofia" AD, SPH: Warsaw Stock Exchange) presents the Annual Audited Individual Financial Statements, which contains:

• XHTML format of the report in accordance with the requirements of Commission Delegated Regulation (EU) 2018/815 of 17 December 2018 supplementing Directive 2004/109/EC of the European Parliament and of the Council with regulatory technical standards on the definition of a common electronic format for reports. It contains:

  • Annual consolidated financial statements
  • Notes to the annual consolidated financial statements
  • Annual management report
  • Corporate governance Declaration
  • Non-financial declaration
  • Declaration by the responsible persons
  • Audit report

• Audit declaration

• Annual reports according to a template determined by the Deputy Chairman of the Financial Supervision Commision;
• Electronic reference to the published inside information under Article 7 of Regulation (EU) №596 / 2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation) and repealing Directive 2003/6 / EC of the European Parliament and of the Council and Commission Directives 2003/124 / EC, 2003/125 / EC and 2004/72 / EC (OJ L 173/1 of 12 June 2014) (Regulation (EU) № 596 / EC) 2014) on the circumstances during the past year:

http://www.x3news.com/?page=News&uniqid=6242d3eba9dc7 https://www.sopharmagroup.com/bg/investitori/novini-za-investitori

Pelagia Viatcheva

Investor Relations Director